Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
International Journal of Cancer|October 23, 2008
Targeting Src signaling in metastatic bone diseaseJohn Araujo, Christopher LogothetisCancer Treatment Reviews|March 16, 2010
Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumorsJohn Araujo, Christopher LogothetisOncology (Williston Park, N.Y.)|July 11, 2002
Docetaxel in the management of advanced or metastatic urothelial tract cancerChristopher Logothetis, Randall MillikanScience Translational Medicine|May 4, 2018
ER stress in prostate cancer: A therapeutically exploitable vulnerability?Christopher Logothetis, Ana Aparicio, Timothy C ThompsonBJU International|March 9, 2011
Current and emerging treatment modalities for metastatic castration-resistant prostate cancerSergio Bracarda, Christopher Logothetis, Cora N Sternberg, et al.Cancer Metastasis Reviews|January 31, 2018
Current perspectives on bone metastases in castrate-resistant prostate cancerChristopher Logothetis, Michael J Morris, Robert Den, et al.BMC Evolutionary Biology|March 18, 2014
Genes with a large intronic burden show greater evolutionary conservation on the protein levelOlga Gorlova, Alexey Fedorov, Christopher Logothetis, et al.Bioinformatics (Oxford, England)|March 26, 2026
CpGene: A Web Application for Epigenetic Signature Identification from DNA Methylation ArraysKonstantinos Lazaros, Souzana Logotheti, Christopher Logothetis, et al.Chronobiology International|September 26, 2012
Actigraphic analysis of the sleep-wake cycle and physical activity level in patients with stroke: implications for clinical practicePaula Cavalcanti, Tania Campos, John AraujoMolecular Cancer Therapeutics|October 14, 2003
Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenograftsSimon Williams, Curtis Pettaway, Rendu Song, et al.Pageof 11